Home Contact Us Site Map
Search for:
Classes & Programs Services
Health Info Find a Job Find a Physician
Mercy Health Center-Fort Scott
Mercy Hospital-Independence
Mercy Physician Group
Mercy Foundations
Health for Life-Fitness Centers
Web Nursery
Women's Services
Visitor Information
Volunteer Opportunities
Privacy Statement
Vendor Resources
 
Home > Health Information > E-Newsletters > Heart Health 

Blood-Thinning Therapy Cuts Stroke Risk

More Warfarin Better In Atrial Fibrillation

Intensive drug therapy to prevent blood clots in people with the heart condition called atrial fibrillation can reduce deaths and damage caused by strokes without increasing the risk of dangerous bleeding, according to a study reported in the New England Journal of Medicine.A picture of a man, on the telephone

It is a finding of life-and-death interest to the growing numbers of US adults with the condition. Incidence of atrial fibrillation increases with age.

An estimated 2.3 million US adults now have atrial fibrillation, and one of every 20 people age 70 or older has the condition.

Atrial fibrillation reduces the heart's ability to pump blood, and the resulting sluggish flow promotes formation of clots that can block brain arteries and cause strokes.

Blood-thinning therapy with aspirin or warfarin, a much more potent anticoagulant, can prevent those clots. But physicians are concerned that too-intensive treatment can cause bleeding in the brain that does the same damage as a clot-caused stroke.

Study Confirms Measured Approach

Atrial fibrillation is the leading cause of stroke among the oldest US adults.

Clotting is measured by what is called the international normalized ratio (INR). A higher INR means freer-flowing blood with a lower risk of clots but a higher risk of dangerous bleeding.

Physicians have known that an INR of 2 or higher can effectively reduce the risk of stroke, but there have been questions about the level at which a higher INR becomes dangerous.

The new study of more than 13,500 patients with atrial fibrillation shows that "the risk of hemorrhage does not increase until you reach an INR of about 4," says Dr. Elaine M. Hylek, at Harvard Medical School and lead researcher on the study.

Previous studies have shown that an INR of 2 or higher can reduce the risk of strokes in patients with atrial fibrillation, Dr. Hylek says.

"This is the first time it has been shown that the severity and mortality of strokes are affected by the intensity of anticoagulation medication," she says.

Physicians Strive for Balance

Not all atrial fibrillation patients receive anticoagulant therapy. Those regarded as having a very low risk of stroke receive no medication at all. Others, at some risk, are told to take aspirin. Warfarin is reserved for the highest-risk patients, because it requires careful monitoring to achieve the desired INR.

A third of the 596 strokes reported in the study occurred in patients taking warfarin. Among those patients, an INR under 2 nearly doubled the risk of having a severe stroke and more than tripled the risk of dying because of the stroke.

Increased risk of bleeding in the brain was found only in INR readings of 3.9 or higher, Dr. Hylek says.

"The message is that patients with atrial fibrillation should maintain an INR at a minimum of 2 or higher," she says. "An INR of about 2.5 should not influence physicians toward a lower level."

The aging of the US population means that more and more people will become aware of the INR and what it means, Dr. Hylek says.

The study "reinforces that we do know the optimal range" of INR readings, says Dr. Robert G. Hart, at the University of Texas Health Sciences Center at San Antonio and author of the accompanying editorial.

A reading between 2 and 3 is best, not only for people with atrial fibrillation but also for those who take warfarin because they have mechanical heart valves, he says.

"For the very elderly with a high risk of bleeding, I would aim at the lower part of that range when possible," Dr. Hart says.

Always consult your physician for more information.

October 2003

Blood-Thinning Therapy Cuts Stroke Risk

Study Confirms Measured Approach

Physicians Strive for Balance

What Is an Arrhythmia?

What Is Atrial Fibrillation?

Online Resources


What Is an Arrhythmia?

Arrhythmias (or dysrhythmias) are abnormal rhythms of the heart which cause the heart to pump less effectively.

Normally, as the electrical impulse moves through the heart, the heart contracts - about 60 to 100 times a minute. Each contraction represents one heartbeat.

The atria contract a fraction of a second before the ventricles so their blood empties into the ventricles before the ventricles contract.

Under some conditions almost all heart tissue is capable of starting a heartbeat, or becoming the pacemaker. An arrhythmia occurs when:

  • the heart's natural pacemaker develops an abnormal rate or rhythm

  • the normal conduction pathway is interrupted

  • another part of the heart takes over as pacemaker

What Is Atrial Fibrillation?

Atrial fibrillation is a type of arrhythmia.

With atrial fibrillation, the electrical signals in the atria (the two small chambers of the heart) are fired in a very fast and uncontrolled manner.

The atria quiver instead of contract. The electrical signals then arrive in the ventricles in an irregular fashion. When the heart does not beat effectively, the blood may pool and/or clot.

If a blood clot becomes lodged in an artery in the brain, a stroke (brain attack) may occur.

About 15 percent of strokes occur in persons with atrial fibrillation.

Aspirin, warfarin, and cardiac medications may be used to treat atrial fibrillation.

Always consult your physician for more information.


Online Resources

(Our Organization is not responsible for the content of Internet sites.)  

American Heart Association

Centers for Disease Control and Prevention (CDC) 

HealthierUS.Gov

National Heart, Lung, and Blood Institute (NHLBI) 

National Institutes of Health (NIH)

A member of the
Sisters of Mercy Health System